Brief Title
Elective Abdominal Aortic Aneurism - Open Versus Endovascular Repair
Official Title
ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal " Surgery Versus Endoprosthesis "
Brief Summary
Abdominal aortic aneurysm (AAA) is a life threatening disease. There is a consensus to propose surgical repair in patients with a reasonable operative risk when the AAA exceeds 5 cm in diameter. The aim of the study is to compare the mortality and the occurrence of severe general, vascular and local complications in two groups of patients treated by either by open surgery or by EVAR (EndoVascular Aneurysm Repair). The main outcome criteria and the secondary endpoint are respectively the survival without severe complications and minor morbidity.
Detailed Description
ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal " Surgery Versus Endoprosthesis Abdominal aortic aneurysm (AAA) is a life threatening disease. There is a consensus to propose surgical repair in patients with a reasonable operative risk when the AAA exceeds 5 cm in diameter. The aim of the study is to compare the mortality and the occurrence of severe general, vascular and local complications in two groups of patients treated by either by open surgery or by EVAR (EndoVascular Aneurysm Repair). The main outcome criteria and the secondary endpoint are respectively the survival without severe complications and minor morbidity.
Study Type
Interventional
Primary Outcome
Death and major adverse events
Secondary Outcome
Minor adverse events (systemic vascular or non vascular complications)
Condition
Elective Abdominal Aortic Aneurysm
Intervention
Endovascular repair (with endograft)
Study Arms / Comparison Groups
1
Description: surgery - open repair
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
306
Start Date
January 2003
Completion Date
February 2009
Primary Completion Date
February 2008
Eligibility Criteria
Inclusion Criteria: - Patients aged 50 years old or more (more than 80 possible depending on physiological age) - Level 0, 1, or 2 of operative risk - Abdominal aortic aneurysm with a diameter > or equal to 50 mm or > or equal to 40 mm if rapid growing (10 mm or more in a year), or painful, or saccular aneurysms, or aneurisms of common iliac arteries with a diameter equal or superior to 30 mm; or women with a diameter equal to 45 mm; - Aortic neck superior or equal to 1.5 cm - No stenosis superior or equal to 75% of the superior mesenteric artery - Proximal neck angulation inferior to 80° - Diameter of the iliac arteries compatible with introducer sheath - Inform consent signed Exclusion Criteria: - Aneurysm involving the renal arteries or with the length of the neck less than 1.5 cm - Thrombus or major calcification in the neck - Diameter of the iliac arteries not compatible with introducer sheath - Level 3 of operative risk - History of major iodine allergy (Quincke oedema, anaphylactic shock) - Other comorbidity with life expectancy less than 6 months - Follow up impossible during the trial - Participation in another trial - Inform consent not signed
Gender
All
Ages
50 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Yann JOUSSET, MD, ,
Location Countries
France
Location Countries
France
Administrative Informations
NCT ID
NCT00224718
Organization ID
P000708
Secondary IDs
AOM 98167
Study Sponsor
Assistance Publique - Hôpitaux de Paris
Study Sponsor
Yann JOUSSET, MD, Principal Investigator, CHU Angers - Hôtel Dieu
Verification Date
February 2009